Aptevo Therapeutics Inc (NQ: APVO )

27.36 USD -0.92 (-3.25%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2021 Add to My Watchlist

Price and Volume

Volume	156,516
Open	28.25
Bid (Size)	27.40 (1)
Ask (Size)	27.99 (1)
Prev. Close	28.28
Today's Range	26.01 - 29.28
52wk Range	5.670 - 60.00
Shares Outstanding	4,449,535
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Aptevo Therapeutics Announces Expansion Phase of Lead Anti-Leukemia Drug APVO436 in Adult Patients with Acute Myeloid Leukemia

May 27, 2021

Aptevo Therapeutics Reports Positive Phase 1 Clinical Data for Its Lead Leukemia Drug Candidate APVO436 in Adults With Relapsed Acute Myeloid Leukemia

May 26, 2021

Performance

YTD	-26.41%	-26.41%
1 Month	+7.84%	+7.84%
3 Month	-15.40%	-15.40%
6 Month	-24.11%	-24.11%
1 Year	+364.52%	+364.52%

More News

Aptevo Therapeutics Reports First Quarter 2021 Financial Results

May 11, 2021

Aptevo Therapeutics to Present at the American Association for Cancer Research Virtual Annual Meeting

April 09, 2021

Aptevo Therapeutics Reports 2020 Financial Results and Provides Business Update

March 31, 2021

Aptevo Confirms Receipt of Nominations and Proposal Notice

February 09, 2021

Aptevo Therapeutics Provides Update on Ongoing APVO436 Phase 1 Clinical Trial

January 11, 2021

Aptevo Therapeutics Announces the Launch of Its Second Platform Technology ADAPTIR-FLEX(TM) and Introduces the New Bispecific Prostate Cancer Candidate APVO442

December 02, 2020

Aptevo Confirms Receipt of Unsolicited Indication of Interest

November 19, 2020

Aptevo Therapeutics Insights: Return On Capital Employed

June 18, 2021

12 Health Care Stocks Moving In Tuesday's Intraday Session

June 15, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.